|
There is hope for us
|
8
|
Zenith Epigenetics
|
Jan 08, 2018 05:10PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
4
|
Resverlogix Corp.
|
Jan 08, 2018 05:18PM
|
|
Pfizer may have given us some good news today
|
1
|
Resverlogix Corp.
|
Jan 08, 2018 05:29PM
|
|
Re: Presentations-FYI...
|
4
|
Resverlogix Corp.
|
Jan 09, 2018 11:37AM
|
|
Re: ANYTHING ON THE SHOWCASE?
|
2
|
Zenith Epigenetics
|
Jan 09, 2018 11:43AM
|
|
Re: Presentation is up
|
4
|
Zenith Epigenetics
|
Jan 09, 2018 01:49PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 12:31AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
2
|
Resverlogix Corp.
|
Jan 11, 2018 01:48AM
|
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
6
|
Resverlogix Corp.
|
Jan 11, 2018 01:23PM
|
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jan 11, 2018 04:39PM
|
|
Re: Questions about the Medison licensing agreement....
|
6
|
Resverlogix Corp.
|
Jan 12, 2018 12:27AM
|
|
Re: Isreal Deal
|
6
|
Resverlogix Corp.
|
Jan 13, 2018 12:36AM
|
|
Re: Isreal Deal
|
1
|
Resverlogix Corp.
|
Jan 13, 2018 10:24PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
7
|
Zenith Epigenetics
|
Jan 16, 2018 12:22AM
|
|
Re: BETonMACE top line data
|
6
|
Resverlogix Corp.
|
Jan 16, 2018 12:58AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Jan 16, 2018 09:22AM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 16, 2018 09:55AM
|
|
Re: BETonMACE top line data
|
2
|
Resverlogix Corp.
|
Jan 16, 2018 12:48PM
|
|
Re: BETonMACE top line data
|
10
|
Resverlogix Corp.
|
Jan 16, 2018 06:26PM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 17, 2018 12:13AM
|
